Hematological Malignancies Program Members

Doralina Anghelescu, MD
Department of Anesthesiology
Research interests: pain management, anesthesia risks, palliative care

Sharyn Baker, PharmD, PhD
Department of Pharmaceutical Sciences
Research interests: clinical pharmacology of tyrosine kinase inhibitors

Deepa Bhojwani, MD
Department of Oncology
Research interests: improving therapy for childhood leukemia/lymphoma

Cheng Cheng, PhD
Department of Biostatistics
Research interests: statistical methods in cancer genomics and genetics

John K. Choi, MD, PhD
Department of Pathology
Research interests: to understand the mechanisms by which the transcription factor E2A regulate normal and leukemic precursor B cell proliferations

Lea C. Cunningham, MD
Department of Bone Marrow Transplantation & Cellular Therapy
Research interests: development of novel immunomodulatory therapies

Mari H. Dallas, MD
Department of Bone Marrow Transplantation & Cellular Therapy
Stem cell and T-cell development; cord blood transplant; infections and immune reconstitution after bone marrow transplant

James Downing, MD
St. Jude President and Chief Executive Officer, Department of Pathology
Research interests: the molecular pathology of acute leukemia

William Evans, PharmD
Department of Pharmaceutical Sciences
Research interests: pharmacogenomics of antileukemic agents in children

Tanja Gruber, MD, PhD
Department of Oncology
Research interests: molecular pathology of infantile leukemia

Hiroto Inaba, MD, PhD
Department of Oncology
Research Interests: novel therapies for leukemia/lymphoma, especially acute myeloid leukemia and lymphoblastic lymphoma

Sima Jeha, MD
Department of Oncology
Research interests: childhood leukemias, developmental therapeutics

Jeffery M. Klco, MD, PhD
Department of Pathology
Research interests: Genomic and functional characterization of acute myeloid leukemia

Mondira Kundu, MD, PhD
Department of Pathology
Research Interests: Mechanisms involved in mitochondrial clearance and links to hematopoietic malignancies

Wing-Hang Leung, MD, PhD
Department of Bone Marrow Transplantation & Cellular Therapy
Research interests: NK cell and stem cell transplantation, late effects

Vasiliki (Vicky) Leventaki, MD
Department of Pathology
Research interests: mechanisms of pathogenesis in pediatric lymphomas

Monika Metzger, MD
Department of Oncology
Research interests: Hodgkin and non-Hodgkin lymphomas, leukemias, IOP

Charles Mullighan, MD, PhD
Department of Pathology
Research interests: genomic profiling of acute leukemia

Stanley Pounds, PhD
Department of Biostatistics
Research interests: develop statistical methods for genomics studies

Ching-Hon Pui, MD
Department of Oncology
Research interests: biology and treatment of childhood leukemia

Mary Relling, PharmD
Department of Pharmaceutical Sciences
Research interests: pharmacokinetics and genetics of leukemia therapy

Raul Ribeiro, MD
Department of Oncology
Research interests: hematological malignancies

Jeffrey Rubnitz, MD, PhD
Department of Oncology
Research interests: treatment of acute myeloid leukemia

John Sandlund, MD
Department of Oncology
Research interests: clinical and biologic investigation of NHL and ALL

Erin Schuetz, PhD
Department of Pharmaceutical Sciences
Research interests: mechanisms of human variation in drug response

John Schuetz, PhD
Department of Pharmaceutical Sciences
Research interests: regulation and function of ABC transporters

Ashok Srinivasan, MD
Department of Bone Marrow Transplant & Cellular Therapy
Research interest: Infections in the immune-compromised host

Brandon Triplett, MD
Department of Bone Marrow Transplantation & Cellular Therapy
Research interests: Hematopoietic cell transplant for high risk leukemia; Use of alternative donors in patients lacking a fully matched sibling donor; Immune reconstitution following hematopoietic cell transplant

Mitchell J. Weiss, MD, PhD
Department of Hematology
Research interests: blood development and associated diseases

Jun J. Yang, PhD
Department of Pharmaceutical Sciences
Research interests: the genomics of hematologic tumors, with particular interests in genomic characterization of inter-patient variability in anti-leukemia drug response and disease susceptibility